Trazodone’s noticeable effects, particularly sedation, typically fade within about five to nine hours after a single dose, though the drug itself lingers in your body considerably longer. The elimination half-life reported in clinical studies ranges from roughly seven hours to thirteen hours depending on conditions like whether you took it with food, which means trace amounts can remain in your system for one to three days. That spread matters more than it sounds, because what “wearing off” means to you depends on whether you care about falling asleep, waking up groggy, or clearing the drug entirely for a medical test or procedure.
What the Half-Life Actually Tells You
The half-life of a drug is the time it takes for your body to reduce the amount in your bloodstream by half. For trazodone, studies have produced somewhat different numbers. One trial measuring a single oral dose in healthy adults found a half-life of about seven hours.1PubMed. Single dose pharmacokinetics of trazodone in healthy subjects Another, conducted under fed conditions, measured the half-life at roughly thirteen hours.2PubMed Central. Pharmacokinetics of single oral dose trazodone: a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition Eating a meal before or with the drug slows absorption and can extend how long it stays in circulation, which partly explains the gap between those numbers.
For practical purposes, most people taking a standard low dose for sleep will find the drowsy feeling fades within four to eight hours, which is why doctors typically recommend taking it shortly before bed. But “wearing off” in terms of how you feel and “wearing off” in terms of measurable blood levels are different things. It generally takes about five half-lives for a drug to be more than 95 percent cleared from your system. Using the shorter estimate, that puts full elimination at about 35 hours. Using the longer estimate, you’re looking at close to three days. In either case, residual amounts of the drug are present long after you stop feeling sleepy.
Why Some People Feel It Much Longer Than Others
Age is one of the biggest factors. A study comparing younger and older adults found that trazodone’s half-life was significantly longer in elderly subjects, and their bodies cleared the drug more slowly. Older adults also remained less alert for a longer stretch after taking it.3PubMed Central. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly The researchers attributed this partly to age-related declines in liver enzyme activity and possibly to changes in how sensitive the brain becomes to the drug’s sedating effects. If you’re over 65 and wondering why trazodone seems to knock you out harder and leave you groggy longer than your younger coworker, the pharmacokinetics back that up.
Genetics play a role too. Trazodone is broken down primarily by a liver enzyme called CYP3A4, but another enzyme, CYP2D6, also contributes. People vary widely in how active their CYP2D6 enzymes are. A pharmacogenetic study found that individuals classified as poor metabolizers through CYP2D6 were roughly nine times more likely to experience adverse drug reactions compared to normal metabolizers.4PubMed Central. CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone: An Explorative Pharmacogenetic Study Poor metabolizers clear the drug more slowly, so for them, trazodone effectively hangs around longer and hits harder. Pharmacogenetic testing is available but not routinely ordered for trazodone prescriptions, so most people discover their metabolizer status the hard way, by noticing they’re unusually sensitive to a standard dose.
Liver function in general matters beyond just genetics. Anyone with liver disease or significantly impaired liver function will process trazodone more slowly. The same goes for body composition: because trazodone distributes into fatty tissue, body weight and fat percentage can influence how quickly it clears. These aren’t dramatic effects for most people, but they add up. Someone who is older, takes other medications, and has a slower-than-average CYP2D6 profile could easily experience effects lasting twice as long as someone younger and healthier on the same dose.
The Dose Changes Everything
Trazodone is unusual because its pharmacology shifts depending on the dose. At the low doses typically prescribed for insomnia, between 25 and 100 milligrams, the drug’s main actions are blocking certain serotonin and histamine receptors, which is what produces the sedating effect.5Psychopharmacology Institute. Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects – Section: Pharmacodynamics and mechanism of action At higher doses used for depression, up to 300 or even 600 milligrams, the drug also begins meaningfully inhibiting serotonin reuptake, which adds a different layer of effects that take longer to build and longer to fade.
This matters for “wearing off” because the sedation from a 50-milligram bedtime dose clears faster than the full pharmacological profile of a 300-milligram antidepressant dose. If you’re taking trazodone only for sleep at a low dose, you can reasonably expect the drowsiness to lift by morning. If you’re on a higher dose for mood, the antidepressant effect isn’t really something that “wears off” between doses in the way sedation does. It builds up over weeks and fades gradually if you stop. These are two very different experiences of the same drug, and the wearing-off question has a different practical answer for each.
The Morning-After Question
One of the most common complaints about trazodone is next-day grogginess. A meta-analysis of trazodone for sleep problems in depressed patients confirmed that sedation and somnolence were significantly more frequent with trazodone than with placebo, with the odds of experiencing daytime sleepiness being several times higher.6PubMed. The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials For some people, this means waking up feeling foggy, uncoordinated, or slow for the first hour or two of the day.
Interestingly, the research on whether that grogginess translates into measurable impairment is mixed. A study testing cognitive and psychomotor performance in primary insomnia patients found no significant effects on driving errors or speeding in a simulated driving test.7PubMed Central. Cognitive, Psychomotor, and Polysomnographic Effects of Trazodone in Primary Insomniacs That said, “no statistically significant effect in a lab” and “I feel fine driving to work” are different standards. If you feel groggy, trust that feeling. Timing your dose earlier in the evening, rather than right before bed, can sometimes help the sedation peak earlier and clear more before your alarm goes off. Working with your doctor to find the lowest effective dose is the most reliable way to reduce next-day carryover.
Drugs That Slow Trazodone’s Clearance
Because CYP3A4 is the primary enzyme that breaks down trazodone, anything that inhibits CYP3A4 will slow the drug’s elimination and effectively make it last longer in your system. Research has shown that ketoconazole, a common antifungal, competitively blocks CYP3A4 from metabolizing trazodone.8PubMed. In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors The same study found that ritonavir and indinavir, both HIV protease inhibitors, had similar inhibitory effects.
The list of CYP3A4 inhibitors extends well beyond those three drugs. Certain antibiotics like clarithromycin, some calcium channel blockers, and even grapefruit juice can meaningfully slow CYP3A4 activity. If you’re taking any strong CYP3A4 inhibitor alongside trazodone, the drug will linger longer in your bloodstream, amplifying both the sedation and any side effects. This is the kind of interaction that doesn’t always get flagged at the pharmacy counter, especially if your trazodone was prescribed by a psychiatrist and the interacting drug comes from a different doctor. It’s worth specifically asking your pharmacist to check for CYP3A4 interactions whenever you start a new medication.
Human liver cells also clear trazodone more slowly than those of other species studied in the lab, which researchers have noted may contribute to the drug’s relatively long duration of action.9PubMed Central. Characterization of trazodone metabolic pathways and species-specific profiles This is mostly relevant to drug development, but it helps explain why trazodone sticks around as long as it does compared to some other sedating medications.
The Active Metabolite That Outlasts the Parent Drug
When your liver processes trazodone, one of the main byproducts is a compound called mCPP (meta-chlorophenylpiperazine). Unlike many drug metabolites that are pharmacologically inactive waste, mCPP is active. It interacts with serotonin receptors and can produce its own set of effects, including anxiety, nausea, and headache in some people.10PubMed. Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects The mCPP metabolite has its own half-life, which means your body is still processing an active compound even after trazodone itself has largely cleared.
For most people at low doses, mCPP levels stay low enough not to cause noticeable problems. But at higher doses, or in people who are CYP2D6 poor metabolizers and thus rely more heavily on the CYP3A4 pathway (which is the one producing mCPP), the metabolite may accumulate to more meaningful levels. This could partly explain why some people feel “off” the day after taking trazodone in a way that doesn’t feel like simple sedation, more like mild anxiety or a headache. It’s the metabolite, not the parent drug, doing that work.
Immediate-Release Versus Extended-Release Formulations
Most trazodone prescribed for sleep in the United States is the immediate-release (IR) tablet, which is absorbed relatively quickly, peaks in about one to two hours, and then declines. There is also a once-a-day (OAD) extended-release formulation designed for depression treatment at higher doses. A modeling study comparing the two found that the low-dose IR formulation achieved high receptor occupancy quickly and maintained relevant activity at certain receptors for well over 24 hours at some binding sites, even on the first day of dosing.11PubMed Central. Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations The higher-dose OAD formulation showed even broader receptor coverage.
The practical takeaway is that even the “fast” version of trazodone doesn’t work like a light switch. The peak sedating effect comes and goes within several hours, but receptor-level activity persists longer than the subjective drowsiness does. If you’re switching between formulations, expect the extended-release version to produce a flatter, more prolonged profile with less of a sharp drowsy peak and more sustained background activity. You may also notice that the morning grogginess is less intense with the OAD formulation (because there’s less of a sharp spike) but that a subtle sense of the drug’s presence stretches further into the day.
How Trazodone Affects Your Sleep Beyond Just Knocking You Out
Part of what makes the “wearing off” question complicated is that trazodone changes the structure of sleep itself, not just how quickly you fall asleep. A meta-analysis found that trazodone increased total sleep time by about 40 minutes on average and significantly boosted the proportion of deep sleep (the slow-wave stage known as N3).12PubMed Central. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis It did not significantly alter REM sleep, which distinguishes it from many other sedating medications that suppress REM.
A separate meta-analysis focused on depressed patients with sleep complaints found a similar pattern: trazodone reduced the proportion of lighter N2 sleep and increased slow-wave sleep.13PubMed Central. Effects of trazodone on polysomnographic sleep architecture in patients with depression and sleep disorders: a systematic review and exploratory meta-analysis This restructuring of sleep architecture may explain why many people report feeling that their sleep quality improved on trazodone, not just the quantity. But it also means that when you stop taking the drug, the shift back to your baseline sleep pattern can feel like a regression even after the drug has fully cleared your system. That’s not the drug still “wearing off” in a pharmacological sense; it’s your sleep architecture readjusting.
What Happens in Overdose
In situations involving much larger amounts than prescribed, trazodone takes longer to clear and can produce dangerous effects in the interim. A published case report described a 45-year-old woman who took five 100-milligram tablets (500 mg total). She initially appeared relatively stable but developed progressive QT prolongation on her EKG, with the interval peaking at 586 milliseconds, a level associated with serious cardiac arrhythmia risk. She also developed low blood pressure.14PubMed Central. Trazodone Overdose Manifesting as Hypotension and QT Prolongation In overdose, the drug’s cardiac effects take hours to fully develop and can require monitoring well beyond the normal wearing-off window. This is fundamentally different from the expected timeline at prescribed doses, and anyone who has taken significantly more trazodone than prescribed should seek emergency medical attention without waiting to see how they feel.
Trazodone and Breastfeeding
For nursing mothers wondering how long to wait after taking trazodone, the picture is relatively reassuring but not without nuance. An older study of six women given a single 50-milligram dose found that the milk-to-plasma ratio was small, and the estimated infant exposure was a tiny fraction of the maternal dose.15PubMed Central. Excretion of trazodone in breast milk A more recent case report, however, found that trazodone and its active metabolite mCPP were present in both cord blood and breast milk at measurable levels, with cord blood concentrations comparable to the mother’s own serum levels about seven hours after dosing.16PubMed Central. Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum
The breast milk concentrations were lower than cord blood, which aligns with the older study’s finding of relatively low milk transfer. But the presence of mCPP in both cord blood and milk is a reminder that the drug’s active metabolite crosses biological barriers too. For a breastfeeding mother taking a nightly low dose, the amount reaching the infant through milk is generally considered small. Timing the dose right after the last evening feeding, to allow several hours of clearance before the next nursing session, is a common strategy, but it’s worth discussing the specifics with a prescriber who knows both your dose and your infant’s health status.
When Trazodone Stops Working for Sleep
A separate “wearing off” concern isn’t about a single dose clearing your system but about the drug losing its effectiveness over time. Unlike benzodiazepines, which are well known for developing tolerance relatively quickly, the evidence on trazodone and tolerance is thinner. A systematic review of trazodone for insomnia noted that the most common side effect is drowsiness and that side effects are dose-dependent, but long-term controlled trials specifically testing whether the sleep benefit diminishes over months are scarce.17PubMed Central. Trazodone for Insomnia: A Systematic Review In practice, many clinicians report that trazodone’s sedating effect remains relatively stable over months to years in most patients, which is one reason it’s so widely prescribed for insomnia despite limited long-term trial data. If you find it becoming less effective, the cause may be a change in your underlying sleep disorder, a new medication interfering with its metabolism, or increased stress rather than pharmacological tolerance to trazodone itself.
If you do want to stop trazodone after long-term use, gradual tapering is generally recommended. Abruptly stopping any drug that modulates serotonin can produce a discontinuation syndrome, and while trazodone’s is generally considered milder than that of SSRIs or SNRIs, some people do report rebound insomnia, irritability, or mood shifts for a few days after stopping. Tapering over one to two weeks, under medical guidance, is the standard approach to minimize these effects.